KCK Ltd.
- SEC CIK
- 0001657662
- Latest filing
- Oct 14, 2025
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Oct 31, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 3
- −1 vs. Q2 2022
- Portfolio value
- $51.6M
- −$19.6M (−27.6%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SGHTSight Sciences, Inc. | COM | 4,776,232 | $30.4M | 58.9% | 00.0% | Unchanged | History |
| NPCENeuroPace Inc | COM | 5,621,111 | $21.1M | 40.9% | 00.0% | Unchanged | History |
| RNTXRein Therapeutics, Inc. | COM | 446,817 | $101.0K | 0.2% | −200,000−30.9% | Reduced | History |
Sold out since Q2 2022 (1)
Positions held at the end of Q2 2022 that are gone from this filing.